Treatment approach, surveillance, and outcome of well-differentiated thyroid cancer in childhood and adolescence

Thyroid

Volumn 24, Issue 7, 2014, Pages 1121-1126

  Markovina, Stephanie ^a   Grigsby, Perry W ^a,b,c   Schwarz, Julie K ^a,b   Dewees, Todd ^a   Moley, Jeffrey F ^a,b   Siegel, Barry A ^b,c   Perkins, Stephanie M ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Washington University in St Louis School of Medicine   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131;

ADOLESCENT; ADOLESCENT DISEASE; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CERVICAL LYMPH NODE; CHILD; CHILDHOOD CANCER; DIFFERENTIATED THYROID CANCER; FEMALE; FOLLOW UP; HUMAN; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIOISOTOPE THERAPY; RISK FACTOR; SALVAGE THERAPY; WHOLE BODY SCINTISCANNING; YOUNG ADULT; AGE; DISEASE FREE SURVIVAL; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL RATE; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SEX FACTORS; SURVIVAL RATE; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84904001273     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2013.0297     Document Type: Article

References (17)

1. Hogan AR, Zhuge Y, Perez EA, Koniaris LG, Lew JI, Sola JE 2009 Pediatric thyroid carcinoma: Incidence and outcomes in 1753 patients. J Surg Res 156:167-172
2. Holmes L, Jr., Hossain J, Opara F 2012 Pediatric thyroid carcinoma incidence and temporal trends in the USA (19732007): Race or shifting diagnostic paradigm?. ISRN Oncol 2012:906197
3. Josefson J, Zimmerman D 2008 Thyroid nodules and cancers in children. Pediatr Endocrinol Rev 6:14-23
4. Luster M, Lassmann M, Freudenberg LS, Reiners C 2007 Thyroid cancer in childhood: Management strategy, including dosimetry and long-Term results. Hormones (Athens) 6:269-278
5. Grigsby PW, Gal-or A, Michalski JM, Doherty GM 2002 Childhood and adolescent thyroid carcinoma. Cancer 95:724-729
6. Newman KD, Black T, Heller G, Azizkhan RG, Holcomb GW, 3rd, Sklar C, Vlamis V, Haase GM, La Quaglia MP 1998 Differentiated thyroid cancer: Determinants of disease progression in patients < 21 years of age at diagnosis: A report from the Surgical Discipline Committee of the Children's Cancer Group. Ann Surg 227:533-541
7. Rivkees SA, Mazzaferri EL, Verburg FA, Reiners C, Luster M, Breuer CK, Dinauer CA, Udelsman R 2011 The treatment of differentiated thyroid cancer in children: Emphasis on surgical approach and radioactive iodine therapy. Endocr Rev 32:798-826
8. American Thyroid Association Guidelines Taskforce on Thyroid N, Differentiated Thyroid C, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214
9. Silberstein EB, Alavi A, Balon HR, Clarke SE, Divgi C, Gelfand MJ, Goldsmith SJ, Jadvar H, Marcus CS, Martin WH, Parker JA, Royal HD, Sarkar SD, Stabin M, Waxman AD 2012 The SNMMI practice guideline for therapy of thyroid disease with 131I 3.0. J Nucl Med 53:1633-1651
10. La Quaglia MP, Black T, Holcomb GW, 3rd, Sklar C, Azizkhan RG, Haase GM, Newman KD 2000 Differentiated thyroid cancer: Clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group. J Pediatr Surg 35:955-959; discussion 960
11. Chow SM, Law SC, Mendenhall WM, Au SK, Yau S, Mang O, Lau WH 2004 Differentiated thyroid carcinoma in childhood and adolescence-clinical course and role of radioiodine. Pediatr Blood Cancer 42:176-183
12. Hung W, Sarlis NJ 2002 Current controversies in the management of pediatric patients with well-differentiated nonmedullary thyroid cancer: A review. Thyroid 12:683-702
13. Alessandri AJ, Goddard KJ, Blair GK, Fryer CJ, Schultz KR 2000 Age is the major determinant of recurrence in pediatric differentiated thyroid carcinoma. Medical and Pediatric Oncology 35:41-46
14. Enomoto K, Enomoto Y, Uchino S, Yamashita H, Noguchi S 2013 Follicular thyroid cancer in children and adolescents: Clinicopathologic features, long-Term survival, and risk factors for recurrence. Endocr J 60:629-635
15. Wada N, Sugino K, Mimura T, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Nakayama H, Hirakawa S, Rino Y, Masuda M, Ito K 2009 Pediatric differentiated thyroid carcinoma in stage I: Risk factor analysis for disease free survival. BMC Cancer 9:306
16. Grigsby PW, Baglan K, Siegel BA 1999 Surveillance of patients to detect recurrent thyroid cancer. Cancer 85:945-951
17. Tubiana M, Schlumberger M, Rougier P, Laplanche A, Benhamou E, Gardet P, Caillou B, Travagli JP, Parmentier C 1985 Long-Term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 55:794-804